Logo image of 1CVS.MI

CVS HEALTH CORP (1CVS.MI) Stock Fundamental Analysis

Europe - BIT:1CVS - US1266501006 - Common Stock

61.18 EUR
+6.37 (+11.62%)
Last: 8/22/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to 1CVS. 1CVS was compared to 28 industry peers in the Health Care Providers & Services industry. 1CVS has a bad profitability rating. Also its financial health evaluation is rather negative. 1CVS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

1CVS had positive earnings in the past year.
In the past year 1CVS had a positive cash flow from operations.
In the past 5 years 1CVS has always been profitable.
Each year in the past 5 years 1CVS had a positive operating cash flow.
1CVS.MI Yearly Net Income VS EBIT VS OCF VS FCF1CVS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

1.2 Ratios

With a Return On Assets value of 1.75%, 1CVS perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
1CVS has a Return On Equity of 5.86%. This is comparable to the rest of the industry: 1CVS outperforms 44.44% of its industry peers.
The Return On Invested Capital of 1CVS (4.57%) is comparable to the rest of the industry.
1CVS had an Average Return On Invested Capital over the past 3 years of 6.22%. This is in line with the industry average of 6.04%.
Industry RankSector Rank
ROA 1.75%
ROE 5.86%
ROIC 4.57%
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
1CVS.MI Yearly ROA, ROE, ROIC1CVS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

The Profit Margin of 1CVS (1.17%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of 1CVS has declined.
Looking at the Operating Margin, with a value of 2.65%, 1CVS is doing worse than 66.67% of the companies in the same industry.
In the last couple of years the Operating Margin of 1CVS has declined.
1CVS's Gross Margin of 13.82% is on the low side compared to the rest of the industry. 1CVS is outperformed by 70.37% of its industry peers.
In the last couple of years the Gross Margin of 1CVS has declined.
Industry RankSector Rank
OM 2.65%
PM (TTM) 1.17%
GM 13.82%
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-18.43%
1CVS.MI Yearly Profit, Operating, Gross Margins1CVS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

2

2. Health

2.1 Basic Checks

1CVS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
1CVS has less shares outstanding than it did 1 year ago.
1CVS has less shares outstanding than it did 5 years ago.
The debt/assets ratio for 1CVS is higher compared to a year ago.
1CVS.MI Yearly Shares Outstanding1CVS.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
1CVS.MI Yearly Total Debt VS Total Assets1CVS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

2.2 Solvency

1CVS has an Altman-Z score of 2.19. This is not the best score and indicates that 1CVS is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of 1CVS (2.19) is comparable to the rest of the industry.
The Debt to FCF ratio of 1CVS is 13.91, which is on the high side as it means it would take 1CVS, 13.91 years of fcf income to pay off all of its debts.
1CVS's Debt to FCF ratio of 13.91 is on the low side compared to the rest of the industry. 1CVS is outperformed by 62.96% of its industry peers.
1CVS has a Debt/Equity ratio of 0.78. This is a neutral value indicating 1CVS is somewhat dependend on debt financing.
1CVS's Debt to Equity ratio of 0.78 is in line compared to the rest of the industry. 1CVS outperforms 51.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 13.91
Altman-Z 2.19
ROIC/WACC0.6
WACC7.58%
1CVS.MI Yearly LT Debt VS Equity VS FCF1CVS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

A Current Ratio of 0.80 indicates that 1CVS may have some problems paying its short term obligations.
1CVS has a Current ratio of 0.80. This is in the lower half of the industry: 1CVS underperforms 70.37% of its industry peers.
A Quick Ratio of 0.62 indicates that 1CVS may have some problems paying its short term obligations.
1CVS has a Quick ratio of 0.62. This is in the lower half of the industry: 1CVS underperforms 70.37% of its industry peers.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.62
1CVS.MI Yearly Current Assets VS Current Liabilites1CVS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

3

3. Growth

3.1 Past

1CVS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.13%.
1CVS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.20% yearly.
The Revenue has been growing slightly by 6.44% in the past year.
1CVS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.74% yearly.
EPS 1Y (TTM)-15.13%
EPS 3Y-13.62%
EPS 5Y-5.2%
EPS Q2Q%-1.09%
Revenue 1Y (TTM)6.44%
Revenue growth 3Y8.47%
Revenue growth 5Y7.74%
Sales Q2Q%8.42%

3.2 Future

Based on estimates for the next years, 1CVS will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.99% on average per year.
Based on estimates for the next years, 1CVS will show a small growth in Revenue. The Revenue will grow by 4.84% on average per year.
EPS Next Y18.42%
EPS Next 2Y15.4%
EPS Next 3Y14.5%
EPS Next 5Y10.99%
Revenue Next Year5.75%
Revenue Next 2Y5.07%
Revenue Next 3Y5.19%
Revenue Next 5Y4.84%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1CVS.MI Yearly Revenue VS Estimates1CVS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100B 200B 300B 400B 500B
1CVS.MI Yearly EPS VS Estimates1CVS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.25, which indicates a very decent valuation of 1CVS.
1CVS's Price/Earnings ratio is rather cheap when compared to the industry. 1CVS is cheaper than 88.89% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.30. 1CVS is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 9.88 indicates a reasonable valuation of 1CVS.
Based on the Price/Forward Earnings ratio, 1CVS is valued cheaply inside the industry as 81.48% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of 1CVS to the average of the S&P500 Index (22.73), we can say 1CVS is valued rather cheaply.
Industry RankSector Rank
PE 11.25
Fwd PE 9.88
1CVS.MI Price Earnings VS Forward Price Earnings1CVS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, 1CVS is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 18.93
EV/EBITDA N/A
1CVS.MI Per share data1CVS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as 1CVS's earnings are expected to grow with 14.50% in the coming years.
PEG (NY)0.61
PEG (5Y)N/A
EPS Next 2Y15.4%
EPS Next 3Y14.5%

6

5. Dividend

5.1 Amount

1CVS has a Yearly Dividend Yield of 3.69%. Purely for dividend investing, there may be better candidates out there.
1CVS's Dividend Yield is rather good when compared to the industry average which is at 2.57. 1CVS pays more dividend than 88.89% of the companies in the same industry.
1CVS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 3.69%

5.2 History

The dividend of 1CVS has a limited annual growth rate of 5.72%.
Dividend Growth(5Y)5.72%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

1CVS pays out 74.62% of its income as dividend. This is not a sustainable payout ratio.
1CVS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP74.62%
EPS Next 2Y15.4%
EPS Next 3Y14.5%
1CVS.MI Yearly Income VS Free CF VS Dividend1CVS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B
1CVS.MI Dividend Payout.1CVS.MI Dividend Payout, showing the Payout Ratio.1CVS.MI Dividend Payout.PayoutRetained Earnings

CVS HEALTH CORP

BIT:1CVS (8/22/2025, 7:00:00 PM)

61.18

+6.37 (+11.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners87.14%
Inst Owner ChangeN/A
Ins Owners0.99%
Ins Owner ChangeN/A
Market Cap77.60B
Analysts77.58
Price Target69.97 (14.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.69%
Yearly Dividend2.27
Dividend Growth(5Y)5.72%
DP74.62%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.87%
Min EPS beat(2)22.99%
Max EPS beat(2)30.76%
EPS beat(4)3
Avg EPS beat(4)13.15%
Min EPS beat(4)-28.4%
Max EPS beat(4)30.76%
EPS beat(8)6
Avg EPS beat(8)5.23%
EPS beat(12)10
Avg EPS beat(12)4.69%
EPS beat(16)14
Avg EPS beat(16)4.93%
Revenue beat(2)2
Avg Revenue beat(2)1.83%
Min Revenue beat(2)0.02%
Max Revenue beat(2)3.64%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-0.46%
Max Revenue beat(4)3.64%
Revenue beat(8)5
Avg Revenue beat(8)0.67%
Revenue beat(12)9
Avg Revenue beat(12)2.1%
Revenue beat(16)13
Avg Revenue beat(16)2.16%
PT rev (1m)0.71%
PT rev (3m)5.78%
EPS NQ rev (1m)-4.11%
EPS NQ rev (3m)-14.98%
EPS NY rev (1m)3.6%
EPS NY rev (3m)7.63%
Revenue NQ rev (1m)1.18%
Revenue NQ rev (3m)-0.09%
Revenue NY rev (1m)1.59%
Revenue NY rev (3m)1.03%
Valuation
Industry RankSector Rank
PE 11.25
Fwd PE 9.88
P/S 0.23
P/FCF 18.93
P/OCF 11.95
P/B 1.17
P/tB N/A
EV/EBITDA N/A
EPS(TTM)5.44
EY8.89%
EPS(NY)6.19
Fwd EY10.12%
FCF(TTM)3.23
FCFY5.28%
OCF(TTM)5.12
OCFY8.37%
SpS261.49
BVpS52.33
TBVpS-27.08
PEG (NY)0.61
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.75%
ROE 5.86%
ROCE 6.23%
ROIC 4.57%
ROICexc 5%
ROICexgc 21.47%
OM 2.65%
PM (TTM) 1.17%
GM 13.82%
FCFM 1.24%
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
ROICexc(3y)6.76%
ROICexc(5y)6.87%
ROICexgc(3y)25.87%
ROICexgc(5y)25.07%
ROCE(3y)8.35%
ROCE(5y)8.51%
ROICexcg growth 3Y-10.65%
ROICexcg growth 5Y-1.15%
ROICexc growth 3Y-14.28%
ROICexc growth 5Y-4.08%
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-18.43%
F-Score5
Asset Turnover1.5
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 13.91
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.72%
Interest Coverage -3.41
Cash Conversion N/A
Profit Quality 105.5%
Current Ratio 0.8
Quick Ratio 0.62
Altman-Z 2.19
F-Score5
WACC7.58%
ROIC/WACC0.6
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.81%
Cap/Sales(5y)0.84%
Profit Quality(3y)191.23%
Profit Quality(5y)191.5%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.13%
EPS 3Y-13.62%
EPS 5Y-5.2%
EPS Q2Q%-1.09%
EPS Next Y18.42%
EPS Next 2Y15.4%
EPS Next 3Y14.5%
EPS Next 5Y10.99%
Revenue 1Y (TTM)6.44%
Revenue growth 3Y8.47%
Revenue growth 5Y7.74%
Sales Q2Q%8.42%
Revenue Next Year5.75%
Revenue Next 2Y5.07%
Revenue Next 3Y5.19%
Revenue Next 5Y4.84%
EBIT growth 1Y-20.52%
EBIT growth 3Y-12.98%
EBIT growth 5Y-4.24%
EBIT Next Year42.57%
EBIT Next 3Y19.26%
EBIT Next 5Y18.23%
FCF growth 1Y-72.95%
FCF growth 3Y-26.21%
FCF growth 5Y-9.45%
OCF growth 1Y-63.11%
OCF growth 3Y-20.7%
OCF growth 5Y-6.65%